Can beta-blockers reduce performance anxiety?

What do beta-blockers actually do for performance anxiety?

Beta-blockers work by blocking the effects of adrenaline on your body. This means they can stop or reduce the physical 'fight or flight' symptoms of anxiety—like a pounding heart, trembling hands, sweaty palms, and a shaky voice. They do not directly change your thoughts or feelings of worry. This is why they are often called 'stage fright' pills: they calm the body, not the mind.

In a 2024 survey of over 300 professional musicians, 57% said they take beta-blockers when auditioning for a job, and 51% use them for performances [2]. The same study found that musicians view beta-blockers as well-tolerated and effective for this purpose. This real-world use is backed by decades of anecdotal reports in classical music, where beta-blockers have been used since the 1970s to control performance anxiety symptoms in high-stakes auditions [5].

But do they actually reduce anxiety, or just hide the symptoms?

This is the key distinction. While beta-blockers clearly reduce physical symptoms, the best available evidence shows they do not reliably reduce the psychological experience of anxiety—the worry, dread, or intrusive thoughts that define anxiety disorders. A 2024 systematic review and meta-analysis of 10 randomized controlled trials found no evidence that beta-blockers are more effective than a placebo or benzodiazepines for treating social phobia or panic disorder [4]. The authors concluded there is a 'lack of robust evidence of effectiveness' for anxiety disorders.

This finding is echoed in other large studies. A 2023 analysis of over 1.4 million people in Sweden found that while beta-blocker use was linked to a 13% lower risk of violent crime (possibly due to reduced 'fight or flight' reactions), it was NOT linked to lower rates of hospitalization for anxiety disorders [6]. Similarly, a 2025 randomized trial of 806 heart attack patients found that beta-blockers did not reduce 'cardiac anxiety' (fear of heart-related symptoms) compared to a control group, except in a small subgroup of patients with moderate anxiety [3]. And a 2024 study of cancer survivors found that starting beta-blockers was actually associated with higher anxiety and lower quality of life, not lower [1].

So who actually benefits, and under what conditions?

The evidence suggests beta-blockers are most useful for people who experience intense physical symptoms of anxiety in specific, high-pressure situations—like a musical audition, a public speech, or a job interview—but who do not have a generalized anxiety disorder. In these cases, the physical symptoms (shaking, racing heart) can themselves worsen performance and feed more anxiety. By breaking that physical feedback loop, beta-blockers can help a person perform closer to their true ability.

This is supported by the musician survey [2] and by clinical practice in sports psychiatry, where beta-blockers are sometimes used short-term for competitive performance anxiety in young athletes and dancers [8]. However, even in these cases, the evidence is not from large, placebo-controlled trials. The 2024 meta-analysis [4] is the strongest evidence we have, and it found no benefit for social phobia—which is essentially severe performance anxiety. This means that for many people, the perceived benefit may be partly a placebo effect, or the drugs may help only a specific subset of people with very prominent physical symptoms.

Importantly, beta-blockers are not a first-line treatment for any anxiety disorder. They are prescribed 'off-label' (not FDA-approved for this use), and many GPs view them as a 'low risk' option, especially for young adults who want a quick fix and are wary of antidepressants [7]. But the lack of evidence for their psychological benefit, combined with potential side effects (fatigue, low blood pressure, and in rare cases, suicidal thoughts in vulnerable individuals [6]), means they should be used cautiously and ideally under medical supervision.

About These Sources

This answer is built on 8 peer-reviewed studies — published from 2023 to 2026, 7 from 2024 or later, 4 in Q1 journals — selected as the most relevant from 13 studies that passed quality screening, drawn from 42 papers retrieved from a database of over 500 million.

Sources used in this answer

Related research questions